NEW YORK (GenomeWeb) – VolitionRx said on Tuesday that it has signed an agreement with Singapore General Hospital to initiate a pilot ovarian cancer study in order to establish the feasibility of the company's NuQ assays to detect the disease.
Already have a GenomeWeb or 360Dx account?Login Now.
360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.
The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.
In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.
Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.